Articles On Adherium (ASX:ADR)

ASX benchmark finishes the flat, after struggling to find traction since mid-morning Health Care romped home to win Best Sector today, up more than 0.4% Errawarra’s nearology has continued to pay off, adding around 50% more today.   Whil...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Digital health company Adherium (ASX:ADR) has signed a collaboration agreement with US-based Allergy Partners with the aim of transforming asthma management for its more than 300,000 patients across 130 sites in 20 states.

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

The ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best and worst performing ASX stocks for the month For the month of July, most major indexes on the ASX rose by around 2.5%. Name % Change...

The ASX 200 built a platform for success today. Which failed. It fell flat at close Sectors wise, Financials, IT and Industrials did okay. The others, very much including Health Care and Utilities, didn’t Notable performers today: Nuix (AS...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

The ASX 200 fell 1.37%, and the bad news kept piling up all day Inflation data knee-capped the market mid-morning, because rate hikes are on the way Two Small Caps hit triple-figure home runs today, which is kinda amazing   Welp… that was...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The ASX 200 benchmark waddled its way to a regrettable 0.45% end to the day Materials the only sector to close on a positive note, up 0.22% Power Minerals wins the day with a canny move from copper-gold to lithium   There wasn’t a whole l...

After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike   As far as days on the ASX go, that definitely...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

ASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today, adding 0.5% on an otherwise fairly moribund day Voltaic Strategic Resources climbs 188% on pre-assay lithium results at Ti Tree   The ASX h...

The ASX 200 turned Hump Day into Slump Day, dropping 1.1% Goldies shone bright under trying conditions to be up more than 2.6% Greentech Metals went ham on the gains, adding 200% while the rest of the market wept   Things haven’t really i...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

The S&P ASX 200 closed up 0.2%, while the S&P XEC fell 0.61% Polymetal Resources soars 64% after announcing thick high grade drill hits at Endeavour polymetallic mine XTEK subsidiary HighCom Armour Solutions signs a collaboration d...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX closes up 0.78%, while XEC rises 1.91% following global markets higher Morningstar warns of possible start of US recession next week spanning 3 quarters, but talk of pause in Aussie rate hikes ‘premature’ Hubify subsidiary Broadland So...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX closes up ~1%, while XEC rises 1.21% following global markets higher Rabobank expects the RBA to raise rates by 0.25% at its April meetig Alice Queen gets funding boost from Queensland Government for Horn Island exploration   The posi...

ASX 200 sinks to -2.2% before recovering to close near -1.5% for the day Energy sector tanks -5.0% because it wants to watch you cry in the shower Low unemployment data sets up the RBA to keep twisting Australia’s nipples, just the way we...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX scuttled by bleak rates outlook in the US, down 0.83% for the day RBA boss Philip Lowe had better news for Aussies. Kind of Summit Resources galloped to a win, up 35% on great REE news at Stallion   We have comments from US Fed chair...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX slid to close flat today, after realising we were in danger of making some money Materials and Energy enjoyed a boost from Chinese manufacturing data Retail theft rates have soared as the cost of living crisis hits hard around the...

The ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers from early flesh wounds to end the day flat Ordinary Aussies ‘outraged’ over changes to super that will never, ever affect them The market has...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month for the privilege of being a captive audience Some Big Names have had shockers as earnings relentlessly keep rolling in   The benchmark has...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Super fund Australian Retirement Trust buys into scandal-plagued Star Entertainment Group State Street Corporation ceases to be a substantial shareholder in Evolution Mining and Sandfire Resources Warrego Energy director sells down stock a...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

The ASX 200 dropped 0.30% and the ASX XEC declined 0.20% Only 4 out of 11 sectors were higher, with Utilities leading the way Waste management company M8 Sustainable receives unsolicited takeover offer   The ASX 200 declined 0.30% today,...

The ASX 200 rose up 0.07%,  ASX XEC was up 0.57% Only 6 out of 11 sectors were higher, with Tech leading the way   Earlier today, Elon Musk said this: No change in copper production is required for the transition to sustainable energy. L...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Adherium (ASX:ADR) has announced an award for a pathfinder service development project from the UK National Health Service’s Small Business Research Initiative Healthcare.

Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million   The...

The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,...

ASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11 sectors finish lower China could reopen next year with ‘seismic’ implications for the rest of the world   The local bourse has dropped for...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX 200 ends 0.7% higher Small cap index flat NYM, BEZ, CPH best in show    Lithium keeps finding another gear. The analysts at Citi lifted target forecasts after the Marrickville government and others besides prepare to throw some suppor...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 halves gains on the run home  Small cap index closes about 0.7% higher Tinkler takes more Jameson, shares jumps 50%   Up strongly this morning following some epic 90’s style US leads on Friday… …the benchmark ASX200 is giving it...